Pin1 is overexpressed and activated in different kinds of cancer including breast, lung, gastric, melanoma, prostrate, ovary and cervical cancers and its overexpression correlates with poor clinical outcome in human cancer patient62,65,78–81. Here, PIN1 is linked to melanoma.